Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
74.34 EUR | +0.34% | +0.64% | +6.45% |
Jun. 07 | Declaration of Voting Results by DuPont de Nemours, Inc | CI |
Jun. 05 | DuPont Appoints James A. Lico to Board of Directors | CI |
Summary
- Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
Strengths
- The earnings growth currently anticipated by analysts for the coming years is particularly strong.
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- Sales forecast by analysts have been recently revised upwards.
- For the past twelve months, EPS forecast has been revised upwards.
- Over the past four months, analysts' average price target has been revised upwards significantly.
- Analyst opinion has improved significantly over the past four months.
- There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.
Weaknesses
- With a 2024 P/E ratio at 30.53 times the estimated earnings, the company operates at rather significant levels of earnings multiples.
- The company's enterprise value to sales, at 3.17 times its current sales, is high.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- Over the past twelve months, analysts' opinions have been revised negatively.
- The group usually releases earnings worse than estimated.
Ratings chart - Surperformance
Sector: Diversified Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+6.45% | 33.48B | - | ||
+3.85% | 79B | B | ||
-8.19% | 43.83B | A- | ||
+14.54% | 18.74B | B | ||
+14.20% | 12.06B | A- | ||
-6.35% | 10.43B | - | ||
-22.45% | 10.17B | B | ||
-2.89% | 8.87B | A- | ||
-3.12% | 8.51B | C- | ||
-13.07% | 5.64B | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- DD Stock
- 4DD Stock
- Ratings DuPont de Nemours, Inc.